Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Feng Liu

Clinical trials sponsored by Feng Liu, explained in plain language.

Not yet recruiting 1

Targeted drug combo aims to shrink Hard-to-Treat head and neck tumors

Disease control Not yet recruiting

This study tests a new drug, becotatug vedotin, combined with an immunotherapy (PD-1 inhibitor) in adults with advanced head and neck squamous cell carcinoma that cannot be surgically removed. The drug targets a protein called EGFR on cancer cells and delivers a toxin directly to…

Phase 2 • Sponsor: Feng Liu • Aim: Disease control

Last updated Jul 08, 2026 00:00 UTC